FIELD: biotechnology.
SUBSTANCE: invention relates to producing precursor renal cells, in which the differentiated pluripotent stem cells are differentiated (iPS-cells) and the cell population is selected from a cell population containing renal precursor cells. Method involves cultivation of iPS-cells under conditions inducing differentiation into renal precursor cells and separation of cell population from cells, obtained at step (i), by selecting by markers of cell surface: CD9(-), CD140a(+), CD140b(+) and CD271(+). Method involves using at least two markers of a cell surface, comprising a combination of one marker of negative selection, selected from a group consisting of CD9(-), CD55(-) and CD326(-), and one positive selection marker selected from a group consisting of CD106(+), CD140a(+), CD140b(+), CD165(+) and CD271(+) or three cell surface markers, comprising a combination of one negative selection marker selected from a group consisting of CD9(-), CD55(-) and CD326(-), and two positive selection markers selected from the group consisting of CD106(+), CD140a(+), CD140b(+), CD165(+) and CD271(+), or three positive selection markers selected from the group consisting of CD106(+), CD140a(+), CD140b(+), CD165(+) and CD271(+). Method involves using two cell surface markers selected from a group consisting of CD9(-), CD140a(+), CD140b(+) and CD271(+).
EFFECT: invention widens the range of equipment.
9 cl, 7 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR BIOLOGICAL PRODUCTION OF LACTATE FROM C1-COMPOUNDS USING TRANSFORMANTS OF LACTATE DEHYDROGENASE | 2014 |
|
RU2710714C2 |
NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
METHOD FOR PRODUCING L-AMINO ACIDS USING CORYNEBACTERIA USING GLYCINE CLEAVAGE SYSTEM | 2015 |
|
RU2713298C2 |
METHOD OF CONTROL OF HEART RHYTHM AND REDUCTION OF INDIVIDUAL CARDIOMYOCYTES USING THERMOGENETICS | 2022 |
|
RU2802995C1 |
MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
HERPES VACCINE | 2019 |
|
RU2731073C1 |
IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
BIOSENSOR SYSTEM FOR FAST DETECTION OF DETERMINED COMPONENTS | 2016 |
|
RU2717658C2 |
INFLUENZA VIRUS CAPABLE OF INFECTING CANINES AND ITS USE | 2020 |
|
RU2802222C2 |
Authors
Dates
2020-08-26—Published
2016-09-09—Filed